ALS pathological mediator identified by researchers 4 September 2019 | By Victoria Rees (Drug Target Review) A potential target for ALS has been revealed by a study which found the Fos-B gene encouraged axonal branching.
Potential sepsis prevention in burn patients found with novel approach 4 September 2019 | By Rachael Harper (Drug Target Review) A new study has demonstrated the possibility of treating antibiotic-resistant Pseudomonas aeruginosa which causes sepsis in burn patients.
Scientists identify promising new target to combat Alzheimer’s disease 4 September 2019 | By Rachael Harper (Drug Target Review) New research is the first to link maladaptive changes in calcium transport by mitochondria to the progression of Alzheimer's disease.
Human digestive tract database available for researchers 3 September 2019 | By Victoria Rees (Drug Target Review) A team from MIT sequenced bacteria samples from the digestive system which can be accessed by researchers to use in the development of treatments.
Sex to be considered as an experimental variable by BJP 3 September 2019 | By Victoria Rees (Drug Target Review) The British Journal of Pharmacology has recommended that all studies it publishes should address sex as an experimental variable.
Pancreas-on-a-chip technology to aid in diabetes research 3 September 2019 | By Rachael Harper (Drug Target Review) Scientists combine organ-on-a-chip and stem-cell technologies to make a powerful tool for diabetes research.
How bacteria behind hospital infections block out antibiotics revealed 3 September 2019 | By Rachael Harper (Drug Target Review) Scientists have shown that drug-resistant bacteria infections shut out antibiotics by closing tiny doors in their cell walls.
AI designed, synthesised and validated new drug in 46 days 2 September 2019 | By Victoria Rees (Drug Target Review) Researchers have developed a new AI system which was able to discover and then successfully test several new compounds within 46 days.
Key pathway discovered in periodontal ligament maturation 2 September 2019 | By Victoria Rees (Drug Target Review) A research team have found a signalling pathway which plays a critical role in the maturation of periodontal ligament, providing information for the development of dental treatments.
Study presents new ways of developing chronic inflammation treatment 2 September 2019 | By Rachael Harper (Drug Target Review) Researchers have found a new way to treat the inflammation involved in chronic diseases.
Tuberculosis vaccine shows efficacy in pre-clinical trials 2 September 2019 | By Victoria Rees (Drug Target Review) Australian researchers have demonstrated the success of a novel TB vaccine in mice, which could provide another treatment option for the disease.
Breast cancer ‘sleeper cells’ could be formed after drug treatment 2 September 2019 | By Rachael Harper (Drug Target Review) Breast cancer medicines may force some cancer cells into 'sleeper mode', allowing them to potentially come back to life after treatment.
Membrane protein function behind epilepsy discovered 30 August 2019 | By Victoria Rees (Drug Target Review) Researchers have revealed the 3D structure of a membrane protein which plays a role in the development of conditions such as epilepsy and blindness.
New treatments for liver disease could be identified with lab-on-a-chip 30 August 2019 | By Rachael Harper (Drug Target Review) New lab on a chip technology has been developed to evaluate the effects of different drivers of NAFLD on liver cells.
Researchers reverse obesity in mice using CRISPR-Cas9 30 August 2019 | By Victoria Rees (Drug Target Review) A study has used CRISPR-Cas9 to treat obesity and type 2 diabetes symptoms in mice, highlighting the potential use in humans.
